Bioprocesas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 16,720 | 25,255 | 71,695 | 136,663 | 153,415 | 116,169 | 122,097 | 220,706 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -47,139 | -51,630 | -22,690 | 561 | 11,258 | 11,288 | -7,908 | 92,106 |
| Equity | 124,353 | 72,723 | 50,033 | 50,594 | 61,852 | 73,140 | 65,232 | 157,338 |
| Liabilities | 28,053 | 41,615 | 50,381 | 50,928 | 51,199 | 41,160 | 47,276 | 55,580 |
| Non-current assets | 29,019 | 15,714 | 6 | 15,767 | 14,647 | 13,528 | 12,409 | 97,375 |
| Current assets | 123,293 | 103,516 | 99,794 | 85,571 | 97,887 | 100,411 | 99,784 | 115,543 |
| Total assets | 152,312 | 119,230 | 99,800 | 101,338 | 112,534 | 113,939 | 112,193 | 212,918 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 20,444 | 14,179 | 32,755 |
| Social insurance contributions | - | - | - | - | - | 2,423 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -69.4% | +51.0% | +183.9% | +90.6% | +12.3% | -24.3% | +5.1% | +80.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -30.9% | -43.3% | -22.7% | 0.6% | 10.0% | 9.9% | -7.0% | 43.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -37.9% | -71.0% | -45.4% | 1.1% | 18.2% | 15.4% | -12.1% | 58.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -281.9% | -204.4% | -31.6% | 0.4% | 7.3% | 9.7% | -6.5% | 41.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.6 | 1.0 | 1.0 | 0.8 | 0.6 | 0.7 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,269 | 6,314 | 15,932 | 42,050 | 76,708 | 42,243 | 56,352 | 101,863 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioprocesas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-07-14 | 0.12 |
| 2026-06-11 | 2026-06-14 | 0.12 |
| 2026-05-18 | 2026-06-08 | 0.12 |
| 2026-05-17 | 2026-05-17 | 428.95 |
| 2026-05-03 | 2026-05-14 | 0.12 |
| 2026-04-24 | 2026-04-29 | 0.12 |
| 2024-04-16 | 2024-05-14 | 0.84 |
| 2024-03-27 | 2024-04-09 | 0.84 |
| 2023-07-18 | 2023-08-06 | 115.71 |
| 2022-02-17 | 2022-03-14 | 0.14 |
| 2022-01-31 | 2022-02-13 | 0.14 |
Bioprocesas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Bioprocesas is: 3,432 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 3432.27 |
| 2026-08-31 | 2026-08-31 | 3401.23 |
| 2026-08-30 | 2026-08-30 | 3395.41 |
| 2026-02-21 | 2026-02-21 | 518.66 |
| 2025-06-14 | 2025-06-14 | 1.38 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOPROCESAS, UAB (code 123066957) is a Private Limited Liability Company engaged in rental and operating of own or leased real estate. In 2025, the company generated EUR 220.7K in revenue and EUR 92.1K in net profit, resulting in a profit margin of 41.7%. This followed a sharp improvement from 2024, when revenue was EUR 122.1K and the company posted a net loss of EUR 7.9K, after a profitable 2023 with EUR 116.2K revenue and EUR 11.3K net profit. Revenue increased by 80.8% year on year in 2025 and by 90.0% over two years. The balance sheet strengthened during the year: total assets rose to EUR 212.9K, equity increased to EUR 157.3K, and liabilities stood at EUR 55.6K. The equity ratio was 73.9% and debt-to-equity 0.35, indicating a solid capital structure. Return on equity reached 58.5% and return on assets 43.3%, while asset turnover was 1.04x. Revenue per employee was EUR 110.4K and profit per employee EUR 46.1K.